Domů › Sarkom měkkých tkání › Texas › Houston
Klinické studie Sarkom měkkých tkání v Houston, TX
32 studií pro Sarkom měkkých tkání hledá účastníky v lokalitách v Houston a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- UT MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Probíhá náborFáze 2
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- MD Anderson Cancer Center, Houston
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Probíhá náborFáze 1/2
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Probíhá náborFáze 1/2
- Baylor College of Medicine, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Probíhá náborFáze 1
- The University of Texas MD Anderson Cancer Center, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1
- The University of Texas MD Anderson Cancer Center, Houston
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Probíhá náborFáze 1/2
- University Of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Probíhá náborFáze 1
- UT MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Probíhá náborFáze 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Probíhá náborFáze 1
- UT MD Anderson Cancer Center, Houston
Actinium Therapy for Late-stage Aggressive Sarcomas
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Probíhá náborFáze 1/2
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Probíhá náborObservační studie
- M D Anderson Cancer Center, Houston
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
Probíhá náborFáze 2
- MD Anderson Cancer Center, Houston
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Probíhá nábor
- M D Anderson Cancer Center, Houston
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
Probíhá náborFáze 1
- The University of Texas M. D. Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Probíhá náborObservační studie
- MD Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Probíhá náborFáze 1/2
- MD Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Probíhá náborFáze 2
- M D Anderson Cancer Center, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Probíhá náborFáze 1/2
- MD Anderson Cancer Center, Houston
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Probíhá náborFáze 2
- M.D. Anderson Children's Cancer Hospital, Houston
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Probíhá náborFáze 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Probíhá nábor
- M D Anderson Cancer Center, Houston
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Probíhá náborFáze 1/2
- The University of Texas MD Anderson Cancer Center, Houston
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Probíhá náborFáze 1
- Texas Children's Hospital, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Probíhá náborFáze 1/2
- The University of Texas MD Anderson Cancer Center, Houston
BostonGene and Exigent Genomic INsight Study
Probíhá náborObservační studie
- Oncology Consultants, Houston
Studie Sarkom měkkých tkání v jiných městech
- New York City, NY19 studií
- Boston, MA18 studií
- St. Louis, MO14 studií
- Los Angeles, CA13 studií
- Columbus, OH13 studií
- Washington, DC12 studií
- Memphis, TN11 studií
- Philadelphia, PA10 studií
- Rochester, MN9 studií
- Nashville, TN9 studií
- Aurora, CO9 studií
- Queens, NY9 studií
Další studie v Houston
- Nemalobuněčný plicní karcinom145 studií
- Rakovina prsu126 studií
- Rakovina (všechny typy)121 studií
- Metastatický karcinom104 studií
- Kolorektální karcinom102 studií
- Rakovina vaječníků89 studií
- Akutní myeloidní leukemie85 studií
- Rakovina plic78 studií
- Rakovina prostaty76 studií
- Rakovina endometria68 studií
- Rakovina slinivky břišní61 studií
- Melanom59 studií
Zdroj: ClinicalTrials.gov, data načtena 3. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.